Treatment with Alstonia scholaris enhances radiosensitivity in vitro and in vivo.
D000470:Alkaloids / Q000302:isolation & purification / Q000627:therapeutic use*; D031051:Alstonia; D000818:Animals; D002286:Carcinoma, Ehrlich Tumor / Q000401:mortality / Q000473:pathology / Q000532:radiotherapy; D002470:Cell Survival / Q000528:radiation effects; D003131:Combined Modality Therapy / Q000379:methods; D004307:Dose-Response Relationship, Radiation; D004353:Drug Evaluation, Preclinical; D005720:Gamma Rays / Q000009:adverse effects; D005978:Glutathione / Q000737:chemistry / Q000187:drug effects; D018922:HL-60 Cells; D006367:HeLa Cells; D006801:Humans; D007267:Injections; D007624:KB Cells; D015227:Lipid Peroxidation / Q000187:drug effects; D051379:Mice; D009368:Neoplasm Transplantation / Q000379:methods; D008517:Phytotherapy; D024301:Plant Bark / Q000737:chemistry; D010936:Plant Extracts / Q000737:chemistry / Q000494:pharmacology; D010946:Plants, Medicinal / Q000737:chemistry; D011836:Radiation Tolerance / Q000187:drug effects* / Q000502:physiology*; D011838:Radiation-Sensitizing Agents / Q000737:chemistry / Q000494:pharmacology / Q000627:therapeutic use
D000470:Alkaloids; D010936:Plant Extracts; D011838:Radiation-Sensitizing Agents; D005978:Glutathione